United States Formalizes Withdrawal from WHO Citing Pandemic Response Concerns
January 23, 2026
Business News

United States Formalizes Withdrawal from WHO Citing Pandemic Response Concerns

Washington cites misalignment of political interests and pandemic management failures as reasons for severing ties with the global health body

Summary

The United States has completed its official exit from the World Health Organization (WHO), citing dissatisfaction with the organization’s handling of the COVID-19 pandemic and a misalignment with American political interests. This move includes halting funding and staff participation in WHO projects, marking a definitive break from the global health agency that the U.S. originally helped establish and financially supports most substantially. The decision followed long-standing criticisms and was previously reversed by a subsequent administration before being carried out once more.

Key Points

The United States has finalized its withdrawal from the World Health Organization, ceasing all funding and staff involvement.
U.S. officials allege the WHO failed in its response to COVID-19, particularly ignoring early warnings from Taiwan and endorsing lockdown measures contrary to robust science.
Despite being a founding member and the largest funder, the U.S. administration criticizes the WHO for pursuing a political agenda inconsistent with American interests.
This withdrawal follows a previous attempt by the Trump administration, which was overturned by the Biden administration, signaling ongoing tensions regarding U.S. participation in the WHO.

The United States government has officially disengaged from the World Health Organization (WHO) in a move underscored by allegations of inadequate pandemic response and political discord between the agency and U.S. priorities. This step fulfilled a promise made by President Donald Trump early in his second term and was publicly confirmed in a joint announcement by Secretary of State Marco Rubio and Secretary of Health and Human Services Robert F. Kennedy Jr.

The official statement detailed that although the U.S. was a founding contributor to the WHO and remains its largest financial backer, it contends that the organization has pursued political aims that diverge from the interests of the United States. This rationale has driven the decision to cease all funding efforts and withdraw U.S. personnel from WHO programs.

Funding and Personnel Withdrawn Amid Criticism of WHO Actions

According to a formal declaration issued by the U.S. Department of State on Thursday, the country has suspended all monetary support and staffing engagements involved in WHO initiatives. The only ongoing interactions with the organization pertain to overseeing a responsible and secure departure strategy to ensure the continued protection of American public health.

Deputy Secretary of Health and Human Services, Jim O’Neill, elaborated on social media platform X that part of the impetus for disengagement stemmed from the WHO’s response to the early stages of the COVID-19 pandemic. He criticized the agency for disregarding timely warnings from Taiwan in 2019 by essentially acting as if Taiwan was non-existent. Additionally, O'Neill claimed that the WHO neglected sound scientific advice and instead advocated for lockdown policies during the pandemic. He emphasized that the U.S. intends to maintain international cooperation on infectious disease matters but explicitly without involvement from the "Eurocrats in Geneva," hinting at a disconnect with the WHO’s leadership and operational framework.

Historical Context and Previous Attempts at Withdrawal

This definitive withdrawal follows a similar attempt initiated by President Trump in 2025, who raised comparable concerns regarding the governance and financial practices of the WHO. That prior decision was reversed when Joe Biden assumed the presidency, but the renewed move indicates a persistent skepticism within parts of the U.S. administration about the organization’s alignment with American interests and its capacity to manage global health crises effectively.

The United States, having been instrumental in founding the WHO, has historically played a significant role both politically and financially. The latest severance, however, illustrates a fundamental and institutional shift in the country’s approach to participation in global health governance mechanisms.

This ongoing disengagement from the WHO has drawn considerable attention regarding the future structure of international health collaboration, given the prominent role the U.S. had in shaping and financing the agency. The implications of this move on global health initiatives and infectious disease management efforts are yet to fully materialize.


Reporting by Caleb Monroe, Consumer Analyst with expertise in market dynamics and organizational behavior in the international health and government sectors.

Risks
  • The cessation of funding and participation may limit U.S. influence over global public health policies and coordination efforts during pandemics.
  • Disengagement from the WHO could potentially impair the United States’ ability to collaborate effectively on international infectious disease control and emergency response.
  • The political discord cited may complicate future re-engagement or cooperation with the WHO or similar global health organizations.
  • Potential gaps in multinational pandemic preparedness and response coordination might arise as a consequence of the U.S. withdrawal.
Disclosure
Education only / not financial advice
Search Articles
Category
Business News

Business News

Ticker Sentiment
WHO - negative
Related Articles
Social Security to Revamp Appointment Scheduling and Claims Processing from March 7, 2026

Starting March 7, 2026, the Social Security Administration (SSA) will implement significant operatio...

UnitedHealth After the Collapse - A Structured Long Trade With Defined Risk

UnitedHealth (UNH) has fallen roughly 50% from its mid-2025 highs and now trades near $273 (as of 02...

Oscar Health Targets Profitability in 2026 Following Challenging 2025

Oscar Health Inc. reported fourth-quarter revenue growth driven by expanding membership but faced in...

Becton Dickinson Faces Market Headwinds Amid Transition and Revised Earnings Projections

Becton Dickinson & Co. posted first-quarter earnings above analyst expectations but trimmed its fisc...

Quest Diagnostics Reports Strong Q4 Earnings and Raises Full-Year Guidance Driving Stock Higher

Quest Diagnostics posted fourth-quarter results surpassing both earnings and revenue expectations, d...

UBS Adjusts Tech Sector Outlook, Advocates Diversification Into Healthcare and Financials

UBS has revised its stance on the U.S. information technology sector from attractive to neutral, hig...